Clinical validation of respiratory outcomes for a patch-based polysomnography system.

Holger Woehrle¹, Christian Viniol², Wolfgang Galetke³, Georg Nilius⁴, Christoph Schöbel⁵, Winfried Randerath⁶, James Leiter⁷, Sebastian Canisius⁸, Hartmut Schneider^9,10,11

¹Lungenzentrum Ulm, Ulm, Germany.

²Universitätsklinikum Gießen und Marburg GmbH, Department of Pneumology, Marburg, Germany.

³VAMED Klinik Hagen-Ambrock, Hagen, Germany.

⁴Klinikum Dortmund gGmbH, University Witten-Herdecke, Dortmund, Germany.

⁵Universitätsmedizin Essen Ruhrlandklinik, Essen, Germany.

⁶Krankenhaus Bethanien, Solingen, Germany.

⁷Department of Molecular and Systems Biology, Geisel School of Medicine, Hanover, NH, USA.

⁸ACliRA Consulting ApS, Tønder, Denmark.

⁹American Sleep Clinic, Frankfurt, Germany.

¹⁰Onera Health, Eindhoven, Netherlands.

¹¹Johns Hopkins University, Baltimore, MD, USA.

PubMed PMC DOI PDF

Abstract

STUDY OBJECTIVES: The Onera Sleep Test System (STS), the first wireless, patch-based, type II polysomnography (PSG) device designed to enable unattended sleep studies at the patient's home, has been introduced. This multicentre study validated data collected from the patch-based PSG against traditional PSG for the classification of sleep-related respiratory events. MATERIALS AND METHODS: Seven cl…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.